27EC Den, Robert B. - Thomas Jefferson University - Thomas Jefferson University
rbd003

Robert B. Den, MD

Contact Dr. Den

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. The landscape of prognostic outlier genes in high-risk prostate cancer
  2. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
  3. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy
  4. Novel targeted siRNA-loaded hybrid nanoparticles: Preparation, characterization and in vitro evaluation
  5. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  6. Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis
  7. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  8. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  9. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  10. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes
  11. Uncertainties encountered in implementation of adaptive planning with in vivo dosimeters
  12. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: Comparative analysis of long-term outcomes
  13. High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer
  14. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  15. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  16. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  17. Practical guide to the use of radium 223 dichloride
  18. High dose rate brachytherapy boost for prostate cancer: A systematic review
  19. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  20. The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
0